Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8–37 fragment of human CGRP
- 9 June 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (11) , 2343-2347
- https://doi.org/10.1016/0006-2952(93)90209-f
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Amylin‐amide: a new bone‐conserving peptide from the pancreasExperimental Physiology, 1990
- Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic isletsDiabetologia, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989
- Effect of calcitonin gene-related peptide on glucose and gastric inhibitory polypeptide-stimulated insulin release from cultured newborn and adult rat islet cellsRegulatory Peptides, 1988
- BIOLOGY OF PEPTIDES FROM THE CALCITONIN GENESQuarterly Journal of Experimental Physiology, 1987
- A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreasBiochemical and Biophysical Research Communications, 1986
- Calcitonin Gene-Related Peptide: Occurrence in Pancreatic Islets in the Mouse and the Rat and Inhibition of Insulin Secretion in the Mouse*Endocrinology, 1986
- Calcitonin gene-related peptide: Novel neuropeptideLife Sciences, 1986
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985
- Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processingNature, 1983